SCHEMBL6016962

SCHEMBL6016962

O=C(NCc1ccccc1)c1nc2ccccc2[nH]1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 2/20 0.65
HDAC3 O15379 1/20 0.65
HDAC1 Q13547 1/20 0.65
SMN1; SMN2 Q16637 2/20 0.64
CNR2 P34972 2/20 0.64
IDO1 P14902 1/20 0.61
NAMPT P43490 1/20 0.59
DAGLA Q9Y4D2 1/20 0.54
FAAH O00519 1/20 0.54
TP53 P04637 1/20 0.54
RAB9A P51151 1/20 0.54
KDM4E B2RXH2 2/20 0.53
PADI4 Q9UM07 1/20 0.53
PADI2 Q9Y2J8 1/20 0.53
ALDH1A1 P00352 2/20 0.53
MAPK1 P28482 2/20 0.53
POLB P06746 1/20 0.53
GAA P10253 1/20 0.53
MAPT P10636 1/20 0.53
USP30 Q70CQ3 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL986732 0.85 HDAC2 (0.68) HDAC2HDAC3HDAC1SMN1; SMN2CNR2
SCHEMBL4930061 0.84 MMP13 (0.65) POLB
SCHEMBL3372970 0.84 CNR2 (0.58) HDAC2HDAC3HDAC1SMN1; SMN2CNR2
SCHEMBL4307360 0.84 EGLN1 (0.67) HDAC2HDAC3HDAC1SMN1; SMN2CNR2
SCHEMBL18765116 0.83 SLC40A1 (0.64)
SCHEMBL24450206 0.82 HDAC3 (0.58) HDAC2HDAC3HDAC1SMN1; SMN2CNR2
SCHEMBL21396304 0.81 FAAH (0.64) HDAC2HDAC3HDAC1SMN1; SMN2IDO1
SCHEMBL4069991 0.81 LMNA (0.57) HDAC2HDAC3HDAC1SMN1; SMN2CNR2
SCHEMBL15685102 0.80 HDAC1 (0.72) HDAC2HDAC3HDAC1
SCHEMBL7423976 0.80 SMYD3 (0.58) HDAC2HDAC3HDAC1SMN1; SMN2CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10759765-B2 Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute CE PHARM CO., LTD. (CN) 2020-09-01 US disclosed
US-20190127337-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE CE PHARM CO., LTD. (CN) 2019-05-02 US disclosed
EP-3444031-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) 2019-02-20 EP disclosed
WO-2017177979-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE 中国科学院上海有机化学研究所 2017-10-19 WO disclosed
EP-1636216-A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS Sanofi-Aventis Deutschland GmbH (DE) 2006-03-22 EP disclosed
WO-2004101553-A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2004-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127337-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE AOC1, AOC2, AOC3 HDAC2 2350/4885HDAC3 1319/4885HDAC1 822/4885
US-10759765-B2 Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute AOC1, AOC2, AOC3 HDAC2 2350/4885HDAC3 1319/4885HDAC1 822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.